Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy [NA]

View source ↗

Summary

This clinical trial compares ergometrine versus carbetocin to decrease blood loss during myomectomy, sponsored by Cairo University, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • Ergometrine (ergometrine)

Snippet

Sponsor: Cairo University | Conditions: Myoma;Uterus | NA | Status: RECRUITING